Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Clin. transl. oncol. (Print) ; 23(3): 459-467, mar. 2021.
Artículo en Inglés | IBECS | ID: ibc-220881

RESUMEN

Purpose This study investigated the degree of tumor cell infiltration in the tumor cavity and ventricle wall based on fluorescent signals of 5-aminolevulinic acid (5-ALA) after removal of the magnetic resonance (MR)-enhancing area and analyzed its prognostic significance in glioblastoma. Methods Twenty-five newly developed isocitrate dehydrogenase (IDH)-wildtype glioblastomas with complete resection both of MR-enhancing lesions and strong purple fluorescence on resection cavity were retrospectively analyzed. The fluorescent signals of 5-ALA were divided into strong purple, vague pink, and blue colors. The pathologic findings were classified into massively infiltrating tumor cells, infiltrating tumor cells, suspicious single-cell infiltration, and normal-appearing cells. The pathological findings were analyzed according to the fluorescent signals in the resection cavity and ventricle wall. Results There was no correlation between fluorescent signals and infiltrating tumor cells in the resection cavity (p = 0.199) and ventricle wall (p = 0.704) after resection of the MR-enhancing lesion. The median progression-free survival (PFS) and median overall survival (OS) were 12.5 (± 2.1) and 21.1 (± 3.5) months, respectively. In univariate analysis, the presence of definitive infiltrating tumor cells in the resection cavity and ventricle wall was significantly related to the PFS (p = 0.002) and OS (p = 0.027). In multivariate analysis, the absence of definitive infiltrating tumor cells improved PFS (hazard ratio: 0.184; 95% CI: 0.049–0.690, p = 0.012) and OS (hazard ratio: 0.124; 95% CI: 0.015–0.998, p = 0.050). Conclusions After resection both of the MR-enhancing lesions and strong purple fluorescence on resection cavity, there was no correlation between remnant fluorescent signals and infiltrating tumor cells (AU)


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Neoplasias Encefálicas/patología , Glioblastoma/patología , Ácido Aminolevulínico , Isocitrato Deshidrogenasa , Fármacos Fotosensibilizantes , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/cirugía , Glioblastoma/metabolismo , Glioblastoma/cirugía , Estimación de Kaplan-Meier , Imagen por Resonancia Magnética , Pronóstico , Supervivencia sin Progresión , Estudios Retrospectivos , Proteínas Supresoras de Tumor/genética
2.
Clin Transl Oncol ; 23(3): 459-467, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32617871

RESUMEN

PURPOSE: This study investigated the degree of tumor cell infiltration in the tumor cavity and ventricle wall based on fluorescent signals of 5-aminolevulinic acid (5-ALA) after removal of the magnetic resonance (MR)-enhancing area and analyzed its prognostic significance in glioblastoma. METHODS: Twenty-five newly developed isocitrate dehydrogenase (IDH)-wildtype glioblastomas with complete resection both of MR-enhancing lesions and strong purple fluorescence on resection cavity were retrospectively analyzed. The fluorescent signals of 5-ALA were divided into strong purple, vague pink, and blue colors. The pathologic findings were classified into massively infiltrating tumor cells, infiltrating tumor cells, suspicious single-cell infiltration, and normal-appearing cells. The pathological findings were analyzed according to the fluorescent signals in the resection cavity and ventricle wall. RESULTS: There was no correlation between fluorescent signals and infiltrating tumor cells in the resection cavity (p = 0.199) and ventricle wall (p = 0.704) after resection of the MR-enhancing lesion. The median progression-free survival (PFS) and median overall survival (OS) were 12.5 (± 2.1) and 21.1 (± 3.5) months, respectively. In univariate analysis, the presence of definitive infiltrating tumor cells in the resection cavity and ventricle wall was significantly related to the PFS (p = 0.002) and OS (p = 0.027). In multivariate analysis, the absence of definitive infiltrating tumor cells improved PFS (hazard ratio: 0.184; 95% CI: 0.049-0.690, p = 0.012) and OS (hazard ratio: 0.124; 95% CI: 0.015-0.998, p = 0.050). CONCLUSIONS: After resection both of the MR-enhancing lesions and strong purple fluorescence on resection cavity, there was no correlation between remnant fluorescent signals and infiltrating tumor cells. The remnant definitive infiltrating tumor cells in the resection cavity and ventricle wall significantly influenced the prognosis of patients with glioblastoma. Aggressive surgical removal of infiltrating tumor cells may improve their prognosis.


Asunto(s)
Ácido Aminolevulínico/metabolismo , Neoplasias Encefálicas/patología , Movimiento Celular , Glioblastoma/patología , Isocitrato Deshidrogenasa , Fármacos Fotosensibilizantes/metabolismo , Anciano , Ácido Aminolevulínico/administración & dosificación , Neoplasias Encefálicas/metabolismo , Neoplasias Encefálicas/mortalidad , Neoplasias Encefálicas/cirugía , Ventrículos Cerebrales/metabolismo , Metilasas de Modificación del ADN/genética , Enzimas Reparadoras del ADN/genética , Femenino , Fluorescencia , Glioblastoma/metabolismo , Glioblastoma/mortalidad , Glioblastoma/cirugía , Humanos , Estimación de Kaplan-Meier , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Fármacos Fotosensibilizantes/administración & dosificación , Pronóstico , Supervivencia sin Progresión , Protoporfirinas/metabolismo , Estudios Retrospectivos , Proteínas Supresoras de Tumor/genética
3.
Spinal Cord ; 46(1): 11-5, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17387315

RESUMEN

STUDY DESIGN: Prospective, cross-sectional, case-control study. SETTING: Outpatient department in Seoul, Korea. OBJECTIVES: To assess prostate volume and serum prostate-specific antigen (PSA) levels in Korean men with spinal cord injury (SCI). METHODS: A total of 31 SCI patients with ages ranging between 45 and 81 years old (median age, 58 years) were studied. Thirty-one age-matched individuals without SCI were enrolled in the study as controls. We tested PSA levels and performed transrectal ultrasonographies on all enrolled patients. Of the patients with SCI, 20 were evaluated for testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) levels. RESULTS: Serum PSA levels and prostate volume parameters in the two groups had similar values: the median (5th-95th percentiles) serum PSA level was 1.56 ng/ml (0.12-9.77) for SCI patients and 1.04 ng/ml (0.50-2.98) for controls (P=0.481), whereas the median (5th-95th percentiles) prostate volume was 18.33 ml (10.16-76.78) for SCI patients and 20.80 ml (14.23-41.22) for controls (P=0.072). No significant differences were found when serum PSA levels and prostate volumes were compared according to SCI patient injury characteristics. Testosterone levels were lower than the normal range in 7 SCI patients (35%), LH was higher than the normal range in 10 SCI patients (20%), and FSH was higher than the normal range in eight SCI patients (40%). We observed an age-related increase in FSH levels (r=0.634, P=0.004), although hormone levels did not correlate with serum PSA levels and prostate volume parameters. CONCLUSIONS: According to our results, serum PSA levels and prostate volume in Korean SCI patients are not different from those in uninjured men and are not affected by injury characteristics.


Asunto(s)
Antígeno Prostático Específico/sangre , Próstata/diagnóstico por imagen , Traumatismos de la Médula Espinal/sangre , Traumatismos de la Médula Espinal/epidemiología , Factores de Edad , Anciano , Anciano de 80 o más Años , Pueblo Asiatico , Sistema Nervioso Autónomo/fisiopatología , Biomarcadores/sangre , Estudios de Casos y Controles , Comorbilidad , Estudios Transversales , Gonadotropinas/sangre , Humanos , Corea (Geográfico)/epidemiología , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Estudios Prospectivos , Próstata/inervación , Próstata/metabolismo , Antígeno Prostático Específico/metabolismo , Traumatismos de la Médula Espinal/fisiopatología , Estadística como Asunto , Testosterona/sangre , Testosterona/metabolismo , Ultrasonografía
4.
Prostate Cancer Prostatic Dis ; 10(2): 143-8, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17199133

RESUMEN

The aim of the study was to assess the utility of prostate-specific antigen (PSA) as a predictor of prostate volume indexes (total prostate volume (TPV), transition zone volume and transition zone index) in Korean men with lower urinary tract symptoms (LUTS). From September 2003 to April 2006, 3431 patients with LUTS were included in the study; they had a median age of 63.8 years, a median prostate volume of 22.6 ml and a median serum PSA of 1.04 ng/ml. Men with a baseline PSA of >10 ng/ml were excluded, to reduce the likelihood of including occult prostate cancer. Prostate volume indexes and serum PSA levels had an age-dependent log-linear relationship. Receiver operating characteristic curve analysis showed that PSA had good predictive value for various prostate volume indexes thresholds. The approximate age-specific criteria for detecting men with a TPV of >40 ml are PSA levels of 1.20, 1.44 and 1.72 ng/ml for men with LUTS in their sixth, seventh and eighth decades, respectively. The results show that serum PSA identifies Korean men with large prostates reasonably well. Korean men may produce and/or release more PSA per unit prostate volume than white men. The cutoffs for PSA and prostate volume to response to LUTS therapy should be determined in this population.


Asunto(s)
Antígeno Prostático Específico/sangre , Próstata/patología , Hiperplasia Prostática/patología , Trastornos Urinarios/sangre , Anciano , Estudios de Cohortes , Humanos , Corea (Geográfico)/epidemiología , Masculino , Persona de Mediana Edad , Hiperplasia Prostática/tratamiento farmacológico , Hiperplasia Prostática/epidemiología , Trastornos Urinarios/epidemiología , Trastornos Urinarios/patología
5.
Minim Invasive Neurosurg ; 49(4): 210-5, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17041831

RESUMEN

A new era of neurosurgery has recently been unveiled with the advent of image-guided surgery. The use of neuronavigation is beginning to have a significant impact on a variety of intracranial procedures. Herein, we report our clinical experience using a neuronavigation system with different surgical applications and techniques for a variety of brain tumors. We used the BrainLab VectorVision neuronavigation system, which is a frameless and image-guided system. We operated on 420 cases having various types of brain tumor with the help of this system. The mean target localizing accuracy and mean volume were 1.15 mm and 30.8 mL (0.2-216.4 mL), respectively. We utilized this system to effectively make bone flaps, to detect critically located, deep-seated, subcortical, skull-base and skull bone tumors, and to operate on intraparenchymal lesions with grossly unclear margins, such as gliomas. We also performed tumor biopsy using the combination of a conventional stereotactic biopsy instrument and an endoscope. The application of the neuronavigation system not only revealed benefits for operative planning, appreciation of anatomy, lesion location and the safety of surgery, but also greatly enhanced surgical confidence.


Asunto(s)
Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/cirugía , Encéfalo/cirugía , Monitoreo Intraoperatorio/métodos , Neuronavegación/métodos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Biopsia/instrumentación , Biopsia/métodos , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Niño , Preescolar , Senos Craneales/anatomía & histología , Senos Craneales/cirugía , Craneotomía/métodos , Endoscopía/métodos , Femenino , Humanos , Lactante , Complicaciones Intraoperatorias/prevención & control , Imagen por Resonancia Magnética/instrumentación , Imagen por Resonancia Magnética/métodos , Masculino , Persona de Mediana Edad , Monitoreo Intraoperatorio/instrumentación , Monitoreo Intraoperatorio/estadística & datos numéricos , Neuronavegación/instrumentación , Neuronavegación/estadística & datos numéricos , Valor Predictivo de las Pruebas , Cuidados Preoperatorios/instrumentación , Cuidados Preoperatorios/métodos , Cráneo/anatomía & histología , Cráneo/cirugía , Tomografía Computarizada por Rayos X/instrumentación , Tomografía Computarizada por Rayos X/métodos
6.
Prostate Cancer Prostatic Dis ; 9(2): 115-20, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16534510

RESUMEN

In addition to androgen, autonomic nerves may be involved in prostatic function. As patients with spinal cord injury (SCI) have impaired innervation of the prostate, the prostate volume and prostate-specific antigen (PSA) level in patients with SCI may be different from those of healthy men. Experiments in rats with SCI indicate that neurogenic factors play an important role in prostate growth and function but the same phenomena may not occur in men with SCI because the current animal models differ from clinical results in humans in several respects. Although many of studies indicate the importance of intact peripheral innervation on the secretory function of the prostate, the effect of more central denervation such as occurs in complete SCI at the cervical, thoracic, or lumbar levels on prostatic function is unclear. In addition, the impact of central nervous system injury on prostatic secretory activity, and consequently on serum PSA levels, is also not clear. Furthermore, the impact of hormonal changes on prostate cancer development and prognosis observed in patients with SCI may also be affected by the level of injury and patient age at the time of injury, which have not been studied. In this article, we review prostate activity and prostate cancer in SCI and discuss how they may relate to neurogenic factors.


Asunto(s)
Andrógenos/metabolismo , Antígeno Prostático Específico/sangre , Neoplasias de la Próstata/etiología , Traumatismos de la Médula Espinal/complicaciones , Adolescente , Adulto , Distribución por Edad , Andrógenos/análisis , Animales , Estudios de Casos y Controles , Modelos Animales de Enfermedad , Estudios de Seguimiento , Humanos , Incidencia , Puntaje de Gravedad del Traumatismo , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Neoplasias de la Próstata/epidemiología , Neoplasias de la Próstata/patología , Ratas , Valores de Referencia , Medición de Riesgo , Traumatismos de la Médula Espinal/diagnóstico
7.
Spinal Cord ; 44(3): 165-9, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16151451

RESUMEN

STUDY DESIGN: Retrospective study, based on cases of spinal cord injury (SCI). OBJECTIVES: To establish hazard ratios for risk of epididymo-orchitis in SCI. SETTING: South Korea. METHODS: A total of 140 male patients injured before 1987 were eligible for this investigation and have been followed up on a yearly basis from January 1987 to December 2003. RESULTS: The average age at which the lesion occurred was 24.8 years old (range, 18-53). The average time since SCI was 16.9 years (range, 1-37). A total of 34 lesions (24.3%) were complete and 106 (75.7%) were incomplete. Over the 17 years, 39 patients (27.9%) were diagnosed with epididymo-orchitis. Epididymo-orchitis was more common for patients with a history of urethral stricture (66.7 versus 25.2%, P=0.014). We also found that epididymo-orchitis was more common for patients on clean intermittent catheterization (CIC) than with indwelling urethral catheterization (42.2% versus 8.3%, P=0.030). In multivariate analysis, patients on CIC had a 7.0-fold higher risk (odds ratio, 6.96; 95% confidence interval, 1.26-38.53; P=0.026); however, a history of urethral stricture lost statistical significance (P=0.074). For other variables, no positive association with epididymo-orchitis was observed. CONCLUSIONS: In this study, CIC was an independent risk factor for the development of epididymo-orchitis in patients with SCI. In addition, our findings suggest that urethral stricture may be a contributing factor for the development of epididymo-orchitis in these patients. Correct instructions about CIC are of utmost importance.


Asunto(s)
Epididimitis/etiología , Orquitis/etiología , Traumatismos de la Médula Espinal/rehabilitación , Vejiga Urinaria Neurogénica/etiología , Vejiga Urinaria/fisiopatología , Cateterismo Urinario/efectos adversos , Adolescente , Adulto , Estudios Transversales , Epididimitis/epidemiología , Humanos , Corea (Geográfico) , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Análisis Multivariante , Orquitis/epidemiología , Centros de Rehabilitación , Estudios Retrospectivos , Factores de Riesgo , Traumatismos de la Médula Espinal/epidemiología
8.
Minim Invasive Neurosurg ; 47(6): 365-8, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15674755

RESUMEN

We have applied the neuronavigation system to endoscopic biopsy and third ventriculostomy in the management of patients with a pineal tumor with hydrocephalus. With the guidance of neuronavigation, the two optimal sites of burr hole and trajectories were planned preoperatively, and the advancing endoscopic device was monitored in real time during the procedure. In our five patients, the diameters of the tumors were 2-3 cm, and the mean systemic accuracy of registration with neuronavigation was 1.2 mm. The biopsy and third ventriculostomy were performed successfully via the respective optimal burr hole and the trajectory determined using preoperative neuronavigation. There were no procedure-related complications, and none of the patients needed another procedure for CSF diversion during the follow-up periods. We present our technique which includes the application of the neuronavigation system to the biopsy and third ventriculostomy in pineal tumor with associated hydrocephalus. This technique can be performed using a simple rigid endoscope via the determined optimal entries and trajectories. The optimal preoperative planning and the intraoperative guidance by neuronavigation are thought to be able to give more chances to minimize the brain injury related to movements or deviation of endoscopic device.


Asunto(s)
Neoplasias Encefálicas/patología , Hidrocefalia/cirugía , Neuroendoscopía , Neuronavegación , Glándula Pineal/patología , Ventriculostomía/métodos , Adolescente , Adulto , Biopsia/métodos , Neoplasias Encefálicas/complicaciones , Neoplasias Encefálicas/cirugía , Estudios de Seguimiento , Humanos , Hidrocefalia/etiología , Masculino , Persona de Mediana Edad , Glándula Pineal/cirugía , Estudios Retrospectivos , Tercer Ventrículo/cirugía
9.
Int J Urol ; 6(1): 13-8, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10221859

RESUMEN

PURPOSE: To compare differences in the number of apoptotic bodies and nuclear shapes (size and roundness) between untreated benign prostate hyperplasia (BPH) and untreated advanced prostate adenocarcinoma (PCA) and to elucidate differences in apoptosis number and nuclear shapes with increasing malignant potentiality, by Gleason score, in PCA. METHODS: A retrospective study was conducted on 40 patients with BPH and 12 patients with PCA I (Gleason score 2-4), 14 patients with PCA II (Gleason score 5-7) and 14 patients with PCA III (Gleason score 8-10). The frequency of apoptotic bodies (mean percentage calculated from 200 cells/high-power field over 10 fields) was examined on immunostain. Nuclear shapes were determined by an automatic image analyzer. Over 100 hyperplastic cells or cancer cells were detected by the image analyzer. RESULTS: The mean number of apoptotic bodies in BPH and PCA I were not significantly different, but patients with PCA II and PCA III showed significantly higher numbers of apoptotic bodies than patients with BPH. Patients with PCA III had significantly more apoptotic bodies than patients with PCA I. Benign prostate hyperplasia nuclei had the smallest mean nuclear area and the largest mean nuclear peripheral ellipse among the four groups. The study showed that PCA I, II, III nuclei had significantly larger areas and a less circular shape than nuclei from patients with BPH. Nuclei from patients with PCA I were smaller in size and rounder than nuclei from patients with PCA III. CONCLUSIONS: The present study clearly shows the presence of apoptosis in BPH and PCA and shows an increasing number of apoptotic bodies with higher cellular malignancy. The nuclear shapes in PCA were more irregular and larger in size with increasing cellular malignancy. As expected, nuclei in BPH were smaller in size and rounder than those of cancer nuclei.


Asunto(s)
Adenocarcinoma/patología , Apoptosis , Núcleo Celular/patología , Hiperplasia Prostática/patología , Neoplasias de la Próstata/patología , Anciano , Anciano de 80 o más Años , Diagnóstico Diferencial , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...